You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 145 No. 11, November 1985 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL OBSERVATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Sarcoidosis and Reactive Pulmonary Hypertension

Robyn J. Barst, MD; Scott J. Ratner, MD

Arch Intern Med. 1985;145(11):2112-2114.


Abstract



• Despite diffuse disease of the lungs (often with widespread inflammation or obliteration of blood vessels) in sarcoidosis, pulmonary hypertension is uncommon, occurring in 1% to 4% of cases. We report a case of sarcoidosis and severe pulmonary hypertension that, in striking contrast to other reports, occurred in the absence of obliterative pulmonary vascular disease. We therefore examined the possibility of whether an abnormality in pulmonary vascular tone might be a cause of the pulmonary hypertension. In pharmacologic studies, we demonstrated pulmonary vasodilatation and, in response to increased pulmonary blood flow, the elaboration of the pulmonary vasoconstricting eicosanoid, thromboxane.

(Arch Intern Med 1985;145:2112-2114)



Author Affiliations



From the Cardiology Division, Departments of Pediatrics (Dr Barst) and Medicine (Dr Ratner), Columbia University College of Physicians and Surgeons, New York. Dr Barst is now with the Department of Pediatrics, New York Medical College, Valhalla.


Footnotes



Accepted for publication March 25, 1985.

Reprint requests to Department of Pediatrics, New York Medical College, Munger Pavilion, Valhalla, NY 10595 (Dr Barst).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pulmonary hypertension in orphan lung diseases
Montani et al.
Orphan Lung Diseases 2011;1:317-331.
ABSTRACT  

Pulmonary sarcoidosis
Lynch 3rd and White
Sarcoidosis 2010;1:105-129.
ABSTRACT  

Treatment of Sarcoidosis-Associated Pulmonary Hypertension: A Two-Center Experience
Barnett et al.
Chest 2009;135:1455-1461.
ABSTRACT | FULL TEXT  

Sarcoidosis-Associated Pulmonary Hypertension: Outcome With Long-term Epoprostenol Treatment
Fisher et al.
Chest 2006;130:1481-1488.
ABSTRACT | FULL TEXT  

Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis
Nunes et al.
Thorax 2006;61:68-74.
ABSTRACT | FULL TEXT  

Distinctive Clinical, Radiographic, and Functional Characteristics of Patients With Sarcoidosis-Related Pulmonary Hypertension
Sulica et al.
Chest 2005;128:1483-1489.
ABSTRACT | FULL TEXT  

The Challenge of Sarcoidosis
Efferen
Chest 2001;120:697-699.
FULL TEXT  

Vasoresponsiveness of Sarcoidosis-Associated Pulmonary Hypertension
Preston et al.
Chest 2001;120:866-872.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.